
Develpin 500mg Tablet ER
Marketer
Lifecare Innovations Pvt Ltd
Salt Composition
Valproic Acid (500mg)
Overview Develpin 500mg Tablet ER
Epilepsy, bipolar disorder, and migraine prevention are addressed by the extended-release Develpin 500mg tablet. Its mechanism involves neuronal calming, promoting cerebral relaxation. Administer Develpin 500mg ER as directed, with or without food, consistently at the same time daily. Missed doses should be taken promptly upon recall. Complete the prescribed course; premature cessation, without physician consultation, risks increased seizure activity. Headache, blurred vision, anorexia, nausea, vomiting, alopecia, and diarrhea are potential side effects. Drowsiness and dizziness may occur, necessitating caution with driving or activities requiring concentration. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report persistent or bothersome side effects to your doctor.
Primary Ingredients of Develpin 500mg Tablet ER
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Develpin 500mg Tablet ER
Managing seizures and epilepsy | Migraine prophylaxis | Treatment of bipolar disorder
Major Benefits of Develpin 500mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Develpin 500mg Extended-Release tablets should be administered with a meal.
Common Side effects of Develpin 500mg Tablet ER:
- Headache
- Dizziness
- Blurred vision
- Loss of appetite
- Nausea
- Vomiting
- Sleepiness
- Hair loss
- Weight gain
- Tremors
- Double vision
- Diarrhea
- Impaired coordination
- Increased appetite
- Weakness
- Stomach pain
How to use Develpin 500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 500mg Develpin ER tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
How Develpin 500mg Tablet ER works:
Epileptic seizures are managed by Develpin 500mg Extended-Release tablets, an anticonvulsant drug. These tablets reduce the hyperactivity of neurons in the brain, thus controlling fits and convulsions.
SAFETY ADVICE
AlcoholUNSAFE
Combining Develpin 500mg Extended-Release Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Develpin 500mg tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Develpin 500mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Develpin 500mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Develpin 500mg Extended-Release tablets. Dosage modification may be necessary. Physician consultation is advised for individuals with pre-existing kidney conditions.
LiverUNSAFE
Develpin 500mg extended-release tablets are contraindicated in patients with hepatic impairment and should be omitted. Medical advice is recommended. The use of Develpin 500mg extended-release tablets is inadvisable for individuals with severe or active liver disease.
What if you forget to take Develpin 500mg Tablet ER :
Should you forget a Develpin 500mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Develpin 500mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Valproate |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Behavior Class | Anti-epileptic drugs targeting sodium channels |
